Hosted on MSN1mon
Crinetics Pharmaceuticals exec sells shares worth $195,350SAN DIEGO—Dana Pizzuti, the Chief Medical (TASE:PMCN) and Development Officer of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX), recently executed a series of stock transactions as disclosed in a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback